Medicine
Drizalma Sprinkle 20 mg delayed-release capsule
Drizalma Sprinkle 20 mg delayed-release capsule is a prescription medicine containing Duloxetine for oral use, marketed by Sun Pharmaceutical Industries, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Duloxetine
- Brand
- Drizalma Sprinkle
- Strength
- 20 mg
- Dosage form
- Delayed-release capsule
- Route
- Oral
- Packs
- 1000 capsules, 30 capsules, 60 capsules and 1 more
- Marketing authorisation holder
- Sun Pharmaceutical Industries
- Manufacturer
- Sun Pharmaceutical IndustriesIndia
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06AX21 Duloxetine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 June 2024
- Identifiers
- RxCUI 2200168, 2200174, 2200175 +5DailyMed set ID b41423b8-dfec-4d79-ba3c-e43a87803d85NDC 47335-616Application NDA212516
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1000 capsule, delayed release in 1 bottle | 47335-616-10 | Sun Pharmaceutical IndustriesIndia | 10 June 2024 |
| 30 capsule, delayed release in 1 bottle | 47335-616-30 | Sun Pharmaceutical IndustriesIndia | 10 June 2024 |
| 60 capsule, delayed release in 1 bottle | 47335-616-60 | Sun Pharmaceutical IndustriesIndia | 10 June 2024 |
| 90 capsule, delayed release in 1 bottle | 47335-616-90 | Sun Pharmaceutical IndustriesIndia | 10 June 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Duloxetine 20 mg delayed-release capsule.
Other strengths and forms of Duloxetine
Clinical summary
Duloxetine is a serotonin and norepinephrine reuptake inhibitor indicated for the treatment of major Depressive Disorder in adults, among other approved uses. It is available as delayed-release capsules for oral use. MedsAcross supplies Duloxetine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DuloxetineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- DRIZALMA SPRINKLE prescribing information (Sun Pharmaceutical Industries) · U.S. National Library of Medicine, DailyMed
- Cymbalta: European public assessment report (EPAR) · European Medicines Agency
- Duloxetine Lilly: European public assessment report (EPAR) · European Medicines Agency
Need Drizalma Sprinkle 20 mg delayed-release capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.